Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...
At Multiple Sclerosis News Today, stories about the keto diet, myelin repair, and vitamin D topped this year's most-read list ...
The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.
People with higher blood levels of certain manufactured compounds that persist in the environment are more likely to be ...
A single dose of Immutep’s MS therapy, IMP761, was well tolerated and reduced T-cell activity for up to 23 days in healthy ...
Disability progression in relapsing MS tends to follow one of four distinct patterns, according to a new study.
Proving her illness created an illusion of wellness for columnist Ahna Crum, but a relapse after nine years showed her she ...
Fear of relapse and worsening disease is common for MS patients, leading to poorer mental health, per a study calling for ...
Although multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) are both neurodegenerative diseases that share some symptoms, there are key differences between them in terms of progression, ...
Multiple sclerosis (MS) is an autoimmune disease thought to arise from a combination of environmental and genetic factors. Over the past decade, a growing body of evidence has identified Epstein-Barr ...
The CEMIP enzyme inhibits the growth of oligodendrocytes and may serve as a therapeutic target to boost myelin repair in MS, ...
A clinical trial testing whether music therapy can make botulinum toxin injections for spasticity more comfortable is recruiting in France.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback